Pain
Conference Coverage
Study busts three migraine trigger myths
Conference Coverage
Migraine and menopause: Longitudinal study shows what to expect
Conference Coverage
Methamphetamine use climbing among opioid users
SAN DIEGO – Co-use is on the rise as availability of meth grows in the shadow of the opioid epidemic.
Conference Coverage
T1D neuropathy declines as glycemic control improves
ORLANDO – New research suggests the rate may have dipped, possibly due to better glycemic control.
From the Journals
Trump support high in counties with chronic opioid use
Policy to abate the opioid crisis must go beyond the medical model to incorporate socioenvironmental disadvantage factors and health behaviors.
Conference Coverage
Mobile app engages individuals with opioid use disorders
Participants’ scores on the medication-assisted treatment attitudes scale rose from a mean of 3.3 to a mean of 3.5 (P = 0.044).
From the Journals
Most U.S. buprenorphine prescribers assess patients for diversion
More than 80% of prescribers are willing to terminate treatment because of diversion concerns, survey shows.
From the Journals
NIH launches HEAL Initiative to combat opioid crisis
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of...
Feature
AMA: Opioid prescriptions down since 2013
Number of providers registered for prescription drug monitoring programs has tripled since 2014.
Conference Coverage
VIDEO: Pills alone not the answer for pain management
SANDESTIN, FLA. – A variety of approaches to pain management is absolutely crucial in the area of opioid abuse.
FDA/CDC
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.